Avage Topical and Insulin Glargine (U-300) Pens
Determining the interaction of Avage Topical and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tazarotene topical
Brand name: Avage, Fabior, Tazorac
Synonyms: Avage
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Avage Topical-Insulin glargine and lixisenatide
- Avage Topical-Insulin glargine and lixisenatide Subcutaneous
- Avage Topical-Insulin glargine, recombinant Subcutaneous
- Avage Topical-Insulin glulisine
- Avage Topical-Insulin Glulisine (Cartridges and Pens)
- Avage Topical-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Avalide
- Insulin Glargine (U-300) Pens-Avanafil
- Insulin Glargine (U-300) Pens-Avandamet
- Insulin Glargine (U-300) Pens-Avandaryl
- Insulin Glargine (U-300) Pens-Avandia
- Insulin Glargine (U-300) Pens-Avapro